Citigroup »

Acelyrin shares owned by Citigroup

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $90k 13k 6.75
2023-12-31 $49k 6.5k 7.46
2023-09-30 $745k 73k 10.17